EUVIMEDEUVIMED entdecken
Crossref

Suppression of the Prostaglandin I2–Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction

Huizhen Lv, Chenchen Wang, Zening Liu, Meixi Quan, Kan Li, Fanglin Gou, Xuelian Shi, Qian Liu iD, Ying Yu iD, Ping Zhu iD, Hui Cheng iD, Tao Cheng und 1 weitere

Circulation · 2025

DOI: 10.1161/circulationaha.124.069420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2025. Verfasst von Huizhen Lv und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, Tianjin Institute of Cardiology, Province and Ministry Co-sponsored Collaborative Innovation Center …. Hauptthemen laut MEDLINE: Myocardial Infarction, Hematopoiesis, Extramedullary, Epoprostenol, Interferon Type I. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Immune cells are closely associated with all processes of cardiac repair after myocardial infarction (MI), including the initiation, development, and resolution of inflammation. Spleen extramedullary hematopoiesis (EMH) serves as a crucial source of emergency mature blood cells that are generated through the self-renewal and differentiation of hematopoietic stem/progenitor cells (HSPCs). However, how EMH responds to MI and the role of EMH in cardiac repair after MI remains unclear. METHODS: To assess the role of spleen EMH in MI, a Tcf21 CreER Scf flox/flox MI mouse model with inhibited EMH was constructed. GFP + (green fluorescent protein) hematopoietic stem cells were sorted from eGFP (enhanced GFP) mouse spleen by flow cytometry and injected into Tcf21 CreER Scf flox/flox mice to test the sources of local inflammatory cells during MI. Using highly specific liquid chromatography–tandem mass spectrometry and single-cell RNA sequencing, we analyzed the lipidomic profile of arachidonic acid metabolites and the transcriptomes of HSPCs in the spleen after MI. RESULTS: We found that MI enhanced EMH, as reflected by the increase in spleen weight and volume and the number of HSPCs in the spleen. The lack of EMH in Scf -deficient mice exacerbated tissue injury after MI. Analysis of the transcriptome of spleen HSPCs after MI revealed that the type 1 interferon pathway was substantially inhibited in hematopoietic stem cell /multipotent progenitor subclusters, and the absence of type 1 interferon signaling enhanced the MI-induced spleen EMH. Lipidomics analysis revealed that prostaglandin I2 (PGI2) was markedly reduced in the spleen. PGI2 suppressed MI-induced EMH through a PGI2 receptor (IP)–cyclic adenosine monophosphate– 453 p-SP1 cascade in spleen HSPCs. Hematopoietic cell–specific IP-deficient mice exhibited enhanced EMH and improved cardiac recovery after MI. CONCLUSIONS: Together, our findings revealed that a PGI2–IFN axis was involved in spleen EMH after MI, providing new mechanistic insights into spleen EMH after MI and offering a new therapeutic target for treating ischemic cardiac injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionHematopoiesis, ExtramedullaryEpoprostenolInterferon Type IAnimalsMiceSpleenHematopoietic Stem CellsSignal TransductionMice, Inbred C57BLDisease Models, AnimalMale

Stichwörter der Autor:innen

extramedullary hematopoiesishematopoietic stem cellsinterferonsmyocardial infarctionprostaglandin

Substanzen

EpoprostenolInterferon Type I

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, Tianjin Institute of Cardiology, Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and…
  • Department of Cardiology, Peking University First Hospital, Beijing, China (H.L., D.A.).
  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
  • Center for Stem Cell Medicine, Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences, Tianjin, China (C.W., F.G., P.Z., H.C., T.C.).
  • School of Biomedical Engineering and Technology (Q.L.), Tianjin Medical University, China.
  • Department of Pharmacology, School of Basic Medical Sciences (Y.Y.), Tianjin Medical University, China.

ORCID-Profile: Qian Liu, Ying Yu, Ping Zhu, Hui Cheng, Ding Ai

Zitieren

APA

Lv, H., Wang, C., Liu, Z., Quan, M., Li, K., Gou, F., Shi, X., Liu, Q., Yu, Y., Zhu, P., Cheng, H., Cheng, T., & Ai, D. (2025). Suppression of the Prostaglandin I2–Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction. Circulation. https://doi.org/10.1161/circulationaha.124.069420

Vancouver

Lv H, Wang C, Liu Z, Quan M, Li K, Gou F, et al. Suppression of the Prostaglandin I2–Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction. Circulation. 2025. doi:10.1161/circulationaha.124.069420

BibTeX
@article{Lv2025,
  author = {Lv, Huizhen and Wang, Chenchen and Liu, Zening and Quan, Meixi and Li, Kan and Gou, Fanglin and Shi, Xuelian and Liu, Qian and Yu, Ying and Zhu, Ping and Cheng, Hui and Cheng, Tao and Ai, Ding},
  title = {Suppression of the Prostaglandin I2–Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction},
  journal = {Circulation},
  year = {2025},
  doi = {10.1161/circulationaha.124.069420}
}
Kostenlos starten →